{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:57:58Z","timestamp":1774670278077,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","jopan.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of PeriAnesthesia Nursing"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jopan.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T11:38:14Z","timestamp":1530617894000},"page":"4-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Perianesthetic Implications and Considerations for Myasthenia Gravis"],"prefix":"10.1016","volume":"34","author":[{"given":"Virginia C.","family":"Muckler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andi N.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jopan.2018.03.009_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-6576.2011.02558.x","article-title":"Anesthesia and myasthenia gravis","volume":"56","author":"Blichfeldt-Lauridsen","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jopan.2018.03.009_bib2","series-title":"Morgan & Mikhail\u2019s Clinical Anesthesiology","first-page":"748","article-title":"Anesthesia for patients with neuromuscular disease","year":"2013"},{"key":"10.1016\/j.jopan.2018.03.009_bib3","series-title":"Stoelting's Anesthesia and Co-Existing Disease","first-page":"507","article-title":"Skin and musculoskeletal diseases","author":"Marschall","year":"2018"},{"key":"10.1016\/j.jopan.2018.03.009_bib4","first-page":"1","article-title":"Perioperative management of neurological conditions","volume":"10","author":"Dhallu","year":"2017","journal-title":"Health Serv Insights"},{"key":"10.1016\/j.jopan.2018.03.009_bib5","unstructured":"Mehrizi M, Fontem RF, Gearhart TR, Pascuzzi RM. Medications and Myasthenia Gravis (A Reference for Health Care Professionals). Myasthenia Gravis Foundation of America. Available at: http:\/\/myasthenia.org\/HealthProfessionals\/EducationalMaterials.aspx. Accessed February 2, 2017."},{"key":"10.1016\/j.jopan.2018.03.009_bib6","series-title":"Clinical Cases in Anesthesia","first-page":"111","article-title":"Myasthenia gravis","author":"Epstein","year":"2014"},{"key":"10.1016\/j.jopan.2018.03.009_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11748-015-0518-y","article-title":"Perioperative management in myasthenia gravis: Republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014","volume":"63","author":"Kadota","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jopan.2018.03.009_bib8","series-title":"Anesthesia and Uncommon Diseases","first-page":"314","article-title":"Muscle diseases","author":"Urban","year":"2012"},{"key":"10.1016\/j.jopan.2018.03.009_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/709480","article-title":"Preoperative high-dose steroid has long-term beneficial effects for myasthenia gravis","volume":"2013","author":"Tetsuka","year":"2013","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.jopan.2018.03.009_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/CND.0b013e31828a0090","article-title":"Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis","volume":"14","author":"Huang","year":"2013","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.jopan.2018.03.009_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.phrs.2012.01.005","article-title":"Meta-analysis: Comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule","volume":"65","author":"Puig","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jopan.2018.03.009_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.thorsurg.2015.04.011","article-title":"Acute intraoperative pulmonary aspiration","volume":"25","author":"Nason","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jopan.2018.03.009_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ALN.0000000000001452","volume":"126","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jopan.2018.03.009_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cen3.12390","article-title":"Management of myasthenia gravis in daily practice for general neurologists and healthcare professionals","volume":"8","author":"Yokoyama","year":"2017","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.jopan.2018.03.009_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.lpm.2014.01.007","article-title":"How to manage the interruption of a treatment with anti-inflammatory corticosteroids?","volume":"43","author":"Kuhn","year":"2014","journal-title":"Presse M\u00e9d"},{"key":"10.1016\/j.jopan.2018.03.009_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7197\/cmj.v38i3.5000146050","article-title":"Myasthenia gravis: Anaesthetic implications and considerations\u2014A report of two cases","volume":"38","author":"Lal","year":"2016","journal-title":"Cumhuriyet Med J"},{"key":"10.1016\/j.jopan.2018.03.009_bib17","first-page":"88","article-title":"Anaesthetic management of a patient with myasthenia gravis for head and neck surgery","volume":"70","author":"Patel","year":"2015","journal-title":"Gujarat Med J"},{"key":"10.1016\/j.jopan.2018.03.009_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/1658-354X.109836","article-title":"Low-dose spinal anesthesia for urgent laparotomy in severe myasthenia gravis","volume":"7","author":"Rodr\u00edguez","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.jopan.2018.03.009_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/TCRM.S93009","article-title":"Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery\u2014A series of 117 cases","volume":"11","author":"Vymazal","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jopan.2018.03.009_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/2249-4472.99317","article-title":"Caesarean section in a patient with myasthenia gravis: A bigger challenge for the anesthesiologist than the obstetrician","volume":"2","author":"Sanwal","year":"2012","journal-title":"J Obstet Anaesth Crit Care"},{"key":"10.1016\/j.jopan.2018.03.009_bib21","series-title":"Millers Anesthesia","first-page":"958","article-title":"Pharmacology of neuromuscular blocking drugs","author":"Naguib","year":"2015"},{"key":"10.1016\/j.jopan.2018.03.009_bib22","first-page":"386","article-title":"Anesthetic implications of myasthenia gravis: A case report","volume":"81","author":"Postevka","year":"2013","journal-title":"AANA J"},{"key":"10.1016\/j.jopan.2018.03.009_bib23","first-page":"172","article-title":"Sevoflurane enhances neuromuscular blockade by increasing the sensitivity of skeletal muscle to neuromuscular blockers","volume":"7","author":"Ye","year":"2015","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.jopan.2018.03.009_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ACO.0000000000000466","article-title":"Anesthetic consideration for neuromuscular diseases","volume":"30","author":"Katz","year":"2017","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.jopan.2018.03.009_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/bja\/aev104","article-title":"Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: A randomized, controlled study","volume":"115","author":"Brueckmann","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jopan.2018.03.009_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/aas.12123","article-title":"Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy","volume":"57","author":"Ulke","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jopan.2018.03.009_bib27","first-page":"53","article-title":"The development and regulatory history of sugammadex in the United States","volume":"30","author":"Murphy","year":"2016","journal-title":"APSF Newsl"},{"key":"10.1016\/j.jopan.2018.03.009_bib28","doi-asserted-by":"crossref","unstructured":"Peringat J, Manappallil RG, Karadan U. Rhabdomyolysis: A rare complication of Hashimoto\u2019 thyroiditis precipitated by statin therapy. BMJ Case Rep. Published online February 12, 2018. https:\/\/doi.org\/10.1136\/bcr-2017-223229.","DOI":"10.1136\/bcr-2017-223229"},{"key":"10.1016\/j.jopan.2018.03.009_bib29","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/MD.0000000000000416","article-title":"Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: An observational study in Japan","volume":"94","author":"Watanabe","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jopan.2018.03.009_bib30","series-title":"Surgical Intensive Care Medicine","first-page":"137","article-title":"Neuromuscular blocking agents","author":"Rodr\u00edguez","year":"2016"},{"key":"10.1016\/j.jopan.2018.03.009_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ejcn.2012.191","article-title":"\u03b2-glucans reduce LDL cholesterol in patients with myasthenia gravis","volume":"67","author":"Hagg\u00e5rd","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jopan.2018.03.009_bib32","doi-asserted-by":"crossref","unstructured":"Mulchandani R, Lyngdoh T, Chakraborty P, Kakkar AK. Statin related adverse effects and patient education: A study from resource limited settings. Acta Cardiol. Published online November 27, 2017. https:\/\/doi.org\/10.1080\/00015385.2017.1406884.","DOI":"10.1080\/00015385.2017.1406884"},{"key":"10.1016\/j.jopan.2018.03.009_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacl.2017.09.006","article-title":"Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the understanding statin use in America and gaps in patient education survey","volume":"12","author":"Jacobson","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jopan.2018.03.009_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2015.08.002","article-title":"Statin-induced myopathy is associated with mitochondrial complex III inhibition","volume":"22","author":"Schirris","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jopan.2018.03.009_bib35","first-page":"00216","article-title":"Factors affect neuromuscular transmission and block","volume":"6","author":"Zwer","year":"2016","journal-title":"J Anesth Crit Care"},{"key":"10.1016\/j.jopan.2018.03.009_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jns.2016.08.057","article-title":"Maintenance immunosuppression in myasthenia gravis","volume":"369","author":"Gotterer","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jopan.2018.03.009_bib37","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0300060516669893","article-title":"Predictors of extubation outcomes following myasthenic crisis","volume":"44","author":"Liu","year":"2016","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jopan.2018.03.009_bib38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/mus.24531","article-title":"Predictive factors for myasthenic crisis after videoscopic thymectomy in patients with myasthenia gravis","volume":"52","author":"Lee","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jopan.2018.03.009_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jocn.2017.11.005","article-title":"Palpebral portion of the orbicularis oculi muscle to repetitive nerve stimulation testing: A potential assessment indicator in patients with generalized myasthenia gravis","volume":"48","author":"Yan","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jopan.2018.03.009_bib40","first-page":"13990","article-title":"Preoperative risk factors for prolonged postoperative ventilation following thymectomy in myasthenia gravis","volume":"8","author":"Lu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jopan.2018.03.009_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1941874412463944","article-title":"Ventilatory management and extubation criteria of the neurological\/neurosurgical patient","volume":"3","author":"Souter","year":"2012","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jopan.2018.03.009_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jopan.2018.03.009_bib43","first-page":"1","article-title":"Neuromuscular monitoring in the perioperative period","volume":"125","author":"Murphy","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jopan.2018.03.009_bib44","first-page":"45","article-title":"Monitoring of neuromuscular blockade: What would you expect if you were the patient?","volume":"30","author":"Stoelting","year":"2016","journal-title":"Anesth Patient Saf Found Newsl"},{"key":"10.1016\/j.jopan.2018.03.009_bib45","first-page":"51","article-title":"Multi-faceted initiative designed to improve safety of neuromuscular blockade","volume":"30","author":"Van Pelt","year":"2016","journal-title":"Anesth Patient Saf Found Newsl"},{"key":"10.1016\/j.jopan.2018.03.009_bib46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: An update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jopan.2018.03.009_bib47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/15360280903098523","article-title":"The challenge of pain management in patients with myasthenia gravis","volume":"23","author":"Haroutiunian","year":"2009","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jopan.2018.03.009_bib48","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/ejcts\/ezx163","article-title":"Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis","volume":"52","author":"Xue","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jopan.2018.03.009_bib49","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jemermed.2017.06.009","article-title":"Myasthenia gravis and crisis: Evaluation and management in the emergency department","volume":"53","author":"Roper","year":"2017","journal-title":"J Emerg Med"}],"container-title":["Journal of PeriAnesthesia Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089947218300844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089947218300844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:17:48Z","timestamp":1761070668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089947218300844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1089947218300844"],"URL":"https:\/\/doi.org\/10.1016\/j.jopan.2018.03.009","relation":{},"ISSN":["1089-9472"],"issn-type":[{"value":"1089-9472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perianesthetic Implications and Considerations for Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of PeriAnesthesia Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jopan.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by American Society of PeriAnesthesia Nurses","name":"copyright","label":"Copyright"}]}}